Tekla Life Sciences Investors

NYSE
HQL
paper.types.company
Rentabilité sur six mois: -12.6%
Rendement en dividendes: 12.99%
Secteur: Financials

12.35 $

0 $ 0%
10.87 $
15.78 $

paper.min_max_per_year

Calendrier des promotions Tekla Life Sciences Investors

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

plus de détails
It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
1992-05-04
ISIN
US87911K1007
Industry
Capital Markets
Sector
Financials
Валюта
usd
Валюта отчета
usd
Див.доход ао
15.3
Дивиденд ао
0.43
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 4.98 3
P/BV 0.94 9
P/E 5.07 10
Efficacité
Nom Signification Grade
ROA 19.76 6
ROE 19.8 6
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 12.99 10
DSI 0.7857 7.86
Croissance moyenne du dividende 7.23 10
Devoir
Nom Signification Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0.0019 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -30.15 0
Rentabilité Ebitda, % -131.71 0
Rentabilité EPS, % -41.09 0
Plus de détails

Dividendes

Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 12.35 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 12.55 $ 0 $ 0 $ -1.59 % 0 % 0 %
common.calendar.number_days.30d 12.51 $ 11.99 $ 12.72 $ -1.28 % 0 % 0 %
common.calendar.number_days.90d 13.43 $ 10.87 $ 13.26 $ -8.04 % 0 % 0 %
common.calendar.number_days.180d 14.13 $ 10.87 $ 14.36 $ -12.6 % 0 % 0 %
common.calendar.number_days.1y 13.05 $ 10.87 $ 15.78 $ -5.36 % 0 % 0 %
common.calendar.number_days.3y 14.6 $ 10.87 $ 16.31 $ -15.41 % 0 % 0 %
common.calendar.number_days.5y 16.52 $ 10.87 $ 22.67 $ -25.24 % 0 % 0 %
common.calendar.number_days.10y 0 $ 10.87 $ 31.13 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 13.5 $ 10.87 $ 14.36 $ -8.52 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Daniel R. Omstead M.S, Ph.D. Principal Executive Officer, President and Trustee N/A 1953 (72 année)
Mr. Peter Branner Chief Investment Officer N/A 1964 (61 année)

Informations sur l'entreprise

Adresse: United States, Boston. MA, 100 Federal Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.teklacap.com/hql.html